A cancer diagnosis brings enormous stress — medical, emotional, and financial. Medicare covers a broad range of cancer treatments, but coverage rules, cost-sharing, and billing settings matter enormously. A single chemotherapy infusion can cost thousands of dollars, and whether you receive it in a hospital outpatient department versus a freestanding infusion center can double or triple your out-of-pocket share.

This guide explains exactly what Medicare covers for cancer treatment, what you can expect to pay, and strategies to protect yourself financially while pursuing the best care.

How Medicare Covers Cancer Treatment

Cancer treatment touches all three main parts of Medicare, and the split can be confusing:

  • Medicare Part A (hospital insurance) covers inpatient hospital stays, skilled nursing facility care after hospitalization, and hospice care
  • Medicare Part B (medical insurance) covers most outpatient cancer services: chemotherapy, radiation therapy, physician visits, diagnostic imaging, and drugs administered in a clinical setting
  • Medicare Part D (prescription drug coverage) covers oral chemotherapy agents and supportive medications taken at home

Original Medicare (Parts A and B) covers the core treatments. Part D fills in oral medications. Medicare Advantage plans must cover everything Original Medicare covers but may have different cost-sharing structures and network requirements.

Chemotherapy Coverage

Chemotherapy is covered under Part B when administered in an outpatient setting (infusion clinic, hospital outpatient department, or physician’s office) and under Part A when given during an inpatient hospital stay.

Intravenous and injectable chemotherapy: Part B covers IV chemo administered by a healthcare provider. You pay the Part B deductible ($257 in 2025) and then 20% coinsurance — but that 20% can be substantial. A single cycle of certain targeted therapies or immunotherapy agents can exceed $10,000, making your 20% share $2,000 or more per infusion.

Oral chemotherapy: Some chemotherapy agents come in pill or capsule form. These fall under Part D, not Part B. The Federal Oral Chemotherapy Parity Law (applicable to most insurance, though not Medicare directly) led Congress to pass the Oral Chemotherapy Parity Act, which took effect for Medicare Part D in 2024. This requires Part D plans to apply the same cost-sharing to oral chemotherapy as to IV chemotherapy. Check your specific plan formulary — oral targeted agents are often on Tier 4 or Tier 5 before the catastrophic threshold.

Biosimilars and targeted therapies: Medicare covers FDA-approved targeted therapies (like trastuzumab for HER2-positive breast cancer, pembrolizumab for multiple cancer types) and biosimilar alternatives when available. Biosimilars typically have lower cost-sharing. Ask your oncologist whether a biosimilar is appropriate for your treatment.

Where You Receive Treatment Matters: Site-of-Care Costs

This is one of the most important cost factors in cancer treatment, and many patients don’t realize it until they receive their bills.

Medicare pays hospitals more than freestanding clinics for the same service — and your cost-sharing is tied to what Medicare pays. A chemotherapy infusion at a hospital outpatient department might cost Medicare $4,000, of which you pay 20% ($800). The same infusion at a freestanding oncology clinic might cost Medicare $1,500, of which you pay 20% ($300).

Hospital outpatient departments have higher facility fees on top of physician fees. When you receive care at a hospital-owned clinic — even if you never set foot in the main hospital building — you’re often billed at hospital outpatient rates.

Freestanding cancer centers and physician offices bill at lower rates for the same services. If your oncologist has privileges at both a hospital outpatient department and a private practice setting, ask whether treatment is available in the lower-cost location.

The Medigap advantage: A Medigap (Medicare Supplement) plan covers your Part B coinsurance, eliminating the site-of-care cost differential. With a Plan G, for example, you pay nothing after the Part B deductible regardless of where you receive treatment. See how Medigap plans compare for a full breakdown.

Radiation Therapy

Medicare Part B covers all standard radiation therapy modalities:

  • External beam radiation (IMRT, VMAT, stereotactic radiosurgery/SRS, SBRT): Covered as outpatient services. You pay 20% coinsurance after the Part B deductible.
  • Brachytherapy (internal radiation seeds/implants): Covered under Part B when performed outpatient; Part A covers inpatient brachytherapy during a hospital stay.
  • Proton beam therapy: Covered for medically appropriate indications. Proton centers are often hospital-based, which affects site-of-care costs.

A full course of radiation therapy (often 15–44 sessions) can create substantial cumulative coinsurance. Medicare Advantage plans may require prior authorization for certain radiation modalities; Original Medicare does not.

Cancer Surgery

Surgery is covered under Part A if it requires a hospital inpatient admission. Most cancer surgeries today are classified as outpatient or same-day surgery and covered under Part B.

Part B outpatient surgery: You pay the Part B deductible and 20% coinsurance. For complex surgeries (Whipple procedure, robotic prostatectomy, major resections), the 20% can be significant.

Part A inpatient surgery: You pay the Part A deductible ($1,676 per benefit period in 2025) plus daily coinsurance for stays over 60 days. For most cancer surgeries, the inpatient stay is short enough that only the deductible applies.

The two-midnight rule: Medicare requires a formal inpatient admission for Part A coverage. Many hospitals classify cancer surgery patients as “outpatient observation” rather than inpatient — even for overnight stays — which means Part A doesn’t apply. This matters enormously for skilled nursing facility coverage after surgery. Always ask your hospital whether you’ve been formally admitted as an inpatient.

Diagnostic Services

Accurate cancer staging requires imaging, biopsies, pathology, and lab work. Medicare Part B covers:

  • CT scans, MRI, and PET scans for staging and treatment monitoring
  • Diagnostic colonoscopy (100% coverage if polyps are found and removed during a screening colonoscopy)
  • Biopsies (performed by surgeon, interventional radiologist, or endoscopist)
  • Pathology and genetic testing (tumor genomic profiling is covered for certain solid tumors)
  • Blood work and tumor marker testing

Liquid biopsies (cell-free DNA tests like Guardant360) are covered by Medicare when ordered for the detection of genetic variants to direct targeted therapy for advanced solid tumor cancers.

Clinical Trials

Medicare covers routine costs associated with qualifying clinical trials. This policy — sometimes called the clinical trials policy — means Medicare pays for standard items and services you would receive even outside a trial (office visits, lab work, imaging, standard treatments given alongside the experimental treatment). It does not pay for the experimental intervention itself, which is typically provided by the trial sponsor at no cost.

Qualifying trials include Phase I, II, and III trials approved by the NIH, NCI, CDC, or the VA, as well as cancer trials registered on ClinicalTrials.gov that meet specific criteria.

This coverage eliminates a significant historical barrier to trial participation. Patients no longer have to choose between accessing experimental treatments and keeping their Medicare coverage.

Ask your oncologist whether clinical trials are available for your cancer type. The NCI’s ClinicalTrials.gov database lists all registered trials with eligibility criteria.

Supportive Care Services

Cancer treatment involves substantial supportive care, and Medicare covers most of it:

  • Antiemetics (nausea/vomiting medications): Covered under Part D for oral antiemetics. Part B covers injectable antiemetics administered in the clinical setting on the same day as chemotherapy.
  • G-CSF (growth factors) like filgrastim (Neupogen) or pegfilgrastim (Neulasta): Part B covers these when administered in-office; Part D covers self-administered versions.
  • Pain management: Part D covers most opioids and adjuvant pain medications. Interventional pain procedures (nerve blocks, intrathecal pump implantation) are covered under Part B or Part A.
  • Mental health services: Part B covers outpatient therapy, psychiatry, and counseling. See Medicare mental health coverage for details.
  • Palliative care: Distinct from hospice, palliative care specialists can be covered under Part B as physician services while you continue active treatment.
  • Nutritional counseling: Medical nutrition therapy is covered for certain conditions including cancer-related malnutrition when ordered by a physician.

Hospice Care

If cancer treatment is no longer effective and you choose comfort-focused care, Medicare Part A covers hospice benefits:

  • All services related to the terminal illness: physician care, nursing, medications, medical equipment, aide services, social work, spiritual counseling, and bereavement support
  • You must forgo curative treatment for the terminal condition to elect hospice, but you can still receive Medicare for unrelated conditions
  • Hospice is covered for two 90-day periods, followed by unlimited 60-day periods, as long as a physician certifies terminal prognosis

Hospice is one of Medicare’s most comprehensive benefits and is often underutilized. Many patients and families wait until the final days; research consistently shows better outcomes and higher satisfaction when hospice is elected earlier.

Extra Help for Low-Income Beneficiaries

Cancer treatment often involves expensive Part D drugs — targeted oral therapies, hormonal agents, and antiemetics. The Extra Help program (Low Income Subsidy) reduces Part D premiums, deductibles, and copayments significantly for beneficiaries with limited income and resources.

In 2025, Extra Help eliminates the Part D deductible and caps copayments at $4.90 (generic) and $12.15 (brand-name) for full-subsidy beneficiaries. For high-cost cancer drugs, this can represent thousands of dollars in annual savings.

Eligibility: income below 150% of the federal poverty level and resources below $17,220 (single) or $34,360 (couple) in 2025. Apply through the Social Security Administration or your State Insurance Assistance Program (SHIP).

The Medicare Savings Programs can further reduce Part A and Part B costs for qualifying beneficiaries.

IRMAA and Cancer Treatment Costs

If your income exceeds certain thresholds, you pay higher Part B and Part D premiums through the Income-Related Monthly Adjustment Amount (IRMAA). See IRMAA Medicare surcharges for the current brackets.

Cancer treatment doesn’t directly affect IRMAA, but a few scenarios interact:

  • Retirement or income reduction: If you stopped working due to cancer, your income may drop significantly. You can appeal IRMAA based on a life-changing event — specifically, work stoppage. See IRMAA appeals and life-changing events.
  • Cashing out investments for treatment costs: Large capital gains in a single year can temporarily spike income and trigger IRMAA two years later. Plan investment liquidations carefully with a financial advisor.

Protecting Yourself Financially: Key Strategies

1. Get a Medigap plan before cancer is diagnosed. Medigap has open enrollment windows tied to Medicare Part B enrollment. Once you’re past that window, insurers can use medical underwriting and deny coverage or charge more. If you’re approaching 65, enroll in a comprehensive Medigap plan (Plan G is the most popular) regardless of your current health. See Medigap plans compared.

2. Check your Medicare Advantage plan’s network before starting treatment. Cancer centers of excellence (like NCI-designated cancer centers) may be out of network for your MA plan. This is a scenario where returning to Original Medicare with Medigap may be advantageous — but re-enrollment rights are limited outside of specific election periods. See Medicare Advantage vs. Original Medicare.

3. Ask about prior authorization requirements. Medicare Advantage plans require prior authorization for many cancer treatments. Start this process immediately when you receive a cancer diagnosis. Delays in prior authorization can delay treatment.

4. Use your SHIP counselor. Each state has a free State Health Insurance Assistance Program that provides one-on-one counseling about Medicare benefits and cost-saving options. Call 1-800-MEDICARE or visit ShipHelp.org.

5. Ask about patient assistance programs. Many cancer drug manufacturers offer copayment assistance programs for patients with high cost-sharing. These programs are available to Medicare patients and can cover significant out-of-pocket drug costs.

What Medicare Doesn’t Cover

  • Experimental treatments not approved by Medicare or outside qualifying clinical trials
  • Most dental care, including tooth extractions before radiation therapy (though some MA plans offer dental benefits)
  • Most vision care (though some MA plans cover routine vision)
  • Transportation to treatment (though some MA plans include transportation benefits)
  • Caregiver services or home care not meeting Medicare’s skilled care requirements

For a cancer patient on Original Medicare, a comprehensive Medigap policy and a Part D plan are the strongest financial protection available. Medicare Advantage may offer additional benefits like transportation and dental, but network restrictions and prior authorization requirements can create barriers to specialist access.

Understanding your Medicare coverage before a cancer diagnosis is the most powerful step you can take. Compare Medigap supplement plans to see which plan best protects you from cancer-related costs, and review Medicare Advantage vs. Original Medicare if you’re deciding between coverage options.